Bengaluru: Biocon Limited on Monday said its wholly owned subsidiary, Biocon Pharma Limited, has received approval from the ...
Biocon’s arm Biocon Pharma has received approval from the US health regulator for its generic version of everolimus tablets for oral suspension used in the treatment of tuberous sclerosis complex, a ...
FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...
Biocon Pharma receives USFDA approval for generic Everolimus tablets, used to treat tuberous sclerosis complex (TSC).
LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
In an exchange filing, the company said the approval covers Everolimus Tablets for Oral Suspension in 2 mg, 3 mg and 5 mg strengths.
MedPage Today on MSN
Gabapentin Under Scrutiny: 2025 Data Challenged Safety Profile
New research questioned old assumptions ...
A double-blind randomized controlled trial published in Epilepsia provides evidence that deep brain stimulation (DBS) of the anterior nucleus of the thalamus can significantly reduce the monthly ...
Here are 4 questions you may want to ask a healthcare provider these question if you want to seek further care.
The increase in early-onset cancers is not necessarily due to a rise in clinically meaningful cancers, researchers argued, but may be due to increased diagnostic scrutiny and overdiagnosis. Of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results